ASO Visual Abstract: Clinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma
This is the largest single-institution series and genomic dataset describing testicular mesothelioma.It identifies unique features, including lower BAP1 alterations compared with other mesotheliomas.Given high metastatic rates, disease-specific guidelines for surgical management and systemic therapies are needed (
Authors
- Garrett M. Nash (ORCID: https://orcid.org/0000-0001-9833-2625)
- Michael David Offin (ORCID: https://orcid.org/0000-0002-7959-3018)
- Marjorie G. Zauderer (ORCID: https://orcid.org/0000-0002-6109-5790)
- Prashasti Agrawal
- Judy Sarungbam (ORCID: https://orcid.org/0000-0002-7443-8123)
- Andrea Cercek (ORCID: https://orcid.org/0000-0002-5054-8192)
- Richard S. Matulewicz (ORCID: https://orcid.org/0000-0003-0757-0885)
- Fady Baky
- Jennifer L. Sauter (ORCID: https://orcid.org/0000-0001-6987-2294)
- Victor E. Reuter
- George J. Bosl
- Charles B. Simone
- Joel Sheinfeld
- William D. Travis
Institutions
- Westchester Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1245/s10434-025-18200-0
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Mesothelioma Applied Research Foundation
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Memorial Sloan-Kettering Cancer Center
- Novocure
- Atara Biotherapeutics
- National Institutes of Health